颈动脉支架内再狭窄的研究进展  

Research progress on in-stent restenosis of carotid artery

作　　者：唐瑜挺 孙非凡 董凌嘉 陈茂华 Tang Yuting;Sun Feifan;Dong Lingjia;Chen Maohua(Department of Neurosurgery,Wenzhou Central Hospital,Wenzhou 325000,China)

机构地区：[1]浙江省温州市中心医院神经外科,325000

出　　处：《中国脑血管病杂志》2024年第10期708-713,共6页Chinese Journal of Cerebrovascular Diseases

基　　金：浙江省卫生健康科技计划(2022ZH009)。

摘　　要：颈动脉狭窄是引起缺血性卒中的主要原因之一,现阶段治疗颈动脉狭窄的手术方式主要有颈动脉内膜切除术与颈动脉支架置入术。颈动脉支架内再狭窄(ISR)是颈动脉支架置入术后的长期并发症之一,严重影响了手术的长期效果和患者的预后,临床上发病率较高。作者在总结国内外研究的基础上,从ISR发生机制、危险因素、治疗选择等方面的最新研究进展进行了综述,以期为临床医师对ISR的诊疗提供借鉴。Carotid artery stenosis is one of the primary causes of ischemic stroke.At present,the main surgical treatments for carotid artery stenosis include carotid endarterectomy(CEA)and carotid artery stenting(CAS).In-stent restenosis(ISR)is a long-term complication after CAS,which significantly affects the long-term outcomes of the surgery and the prognosis of patients,with a relatively high incidence in clinical practice.Based on a review of domestic and international studies,the authors provided a comprehensive overview of ISR,covering its pathogenesis,risk factors,treatment options,and the latest research developments,in order to provide clinicians with guidance for the diagnosis and treatment of ISR.

关 键 词：颈动脉狭窄 颈动脉支架置入术 支架内再狭窄 综述 

分 类 号：R651.12[医药卫生—外科学]